SE435507B - Forfarande for framstellning av trimetoxifenoxi-propyl-piperezinderivat - Google Patents

Forfarande for framstellning av trimetoxifenoxi-propyl-piperezinderivat

Info

Publication number
SE435507B
SE435507B SE7803742A SE7803742A SE435507B SE 435507 B SE435507 B SE 435507B SE 7803742 A SE7803742 A SE 7803742A SE 7803742 A SE7803742 A SE 7803742A SE 435507 B SE435507 B SE 435507B
Authority
SE
Sweden
Prior art keywords
carbon atoms
acid
group
piperazine
groups
Prior art date
Application number
SE7803742A
Other languages
English (en)
Swedish (sv)
Other versions
SE7803742L (sv
Inventor
A Kleemann
V Jakovlev
K Thiemer
J Engel
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of SE7803742L publication Critical patent/SE7803742L/xx
Publication of SE435507B publication Critical patent/SE435507B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7803742A 1977-04-04 1978-04-03 Forfarande for framstellning av trimetoxifenoxi-propyl-piperezinderivat SE435507B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB14100/77A GB1583372A (en) 1977-04-04 1977-04-04 1-(3-(3,4,5-trimethoxyphenoxy)-2-hydroxypropyl)-4-aryl piperazine derivatives

Publications (2)

Publication Number Publication Date
SE7803742L SE7803742L (sv) 1978-10-05
SE435507B true SE435507B (sv) 1984-10-01

Family

ID=10034980

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7803742A SE435507B (sv) 1977-04-04 1978-04-03 Forfarande for framstellning av trimetoxifenoxi-propyl-piperezinderivat

Country Status (23)

Country Link
JP (1) JPS6038383B2 (es)
AR (1) AR222149A1 (es)
AT (1) AT360997B (es)
AU (1) AU516315B2 (es)
BE (1) BE865642A (es)
CA (1) CA1124718A (es)
CH (1) CH638795A5 (es)
CS (1) CS249503B2 (es)
DE (1) DE2814168A1 (es)
DK (1) DK145225C (es)
ES (1) ES468486A1 (es)
FI (1) FI69627C (es)
FR (1) FR2395264A1 (es)
GB (1) GB1583372A (es)
HU (1) HU179952B (es)
MX (1) MX6120E (es)
NL (1) NL7803540A (es)
NO (1) NO149209C (es)
PL (1) PL112249B1 (es)
SE (1) SE435507B (es)
SU (1) SU893133A3 (es)
YU (1) YU40513B (es)
ZA (1) ZA781889B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335126A (en) * 1977-03-10 1982-06-15 Degussa Aktiengesellschaft 1-[3-(3,4,5-Trimethoxyphenoxy)-2-hydroxy-propyl]-4-aryl-piperazine-derivatives having pharmaceutical activity
FR2488892A2 (fr) * 1977-04-04 1982-02-26 Degussa Nouveaux derives 1-(3-(3,4,5-trimethoxyphenoxy)-2-hydroxypropyl)-4-aryl-piperaziniques, procede pour leur preparation et leur application en tant que medicament
DE2824764A1 (de) * 1978-06-06 1979-12-20 Hoechst Ag Neue pyridylpiperazinderivate und verfahren zu ihrer herstellung
DE3023369A1 (de) * 1980-06-23 1982-01-14 Boehringer Mannheim Gmbh, 6800 Mannheim Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2568878B1 (fr) * 1984-08-07 1986-11-21 Cortial Nouveaux derives de (phenylpiperazinylethylamine ethoxy)-4 phenol, leur methode de preparation et leur application therapeutique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA967965A (en) * 1968-12-24 1975-05-20 Hoffmann-La Roche Limited Aromatic ethers and process for the manufacture thereof
FR2068051A5 (es) * 1969-11-26 1971-08-20 Robert Jean
CA1012540A (en) * 1972-06-17 1977-06-21 Sumitomo Chemical Company 2-propanol derivatives and preparation thereof
DE2235597A1 (de) * 1972-07-20 1974-01-31 Boehringer Mannheim Gmbh 1-eckige klammer auf 3-(5,6,7,8tetrahydronaphth-1-yl-oxy) -propyl eckige klammer zu -piperazin-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
GB1583372A (en) 1981-01-28
FI781009A (fi) 1978-10-05
FR2395264B1 (es) 1980-03-07
CA1124718A (en) 1982-06-01
ZA781889B (en) 1979-03-28
DK145225C (da) 1983-04-11
AT360997B (de) 1981-02-10
CS249503B2 (en) 1987-03-12
MX6120E (es) 1984-11-19
SE7803742L (sv) 1978-10-05
ATA233078A (de) 1980-07-15
FI69627C (fi) 1986-03-10
HU179952B (en) 1983-01-28
NO149209B (no) 1983-11-28
DK146678A (da) 1978-10-05
NO149209C (no) 1984-03-07
ES468486A1 (es) 1979-01-16
YU76778A (en) 1982-10-31
SU893133A3 (ru) 1981-12-23
NO781159L (no) 1978-10-05
CH638795A5 (en) 1983-10-14
JPS53130682A (en) 1978-11-14
AU516315B2 (en) 1981-05-28
YU40513B (en) 1986-02-28
DK145225B (da) 1982-10-11
AU3470378A (en) 1979-10-11
DE2814168A1 (de) 1978-10-05
FI69627B (fi) 1985-11-29
JPS6038383B2 (ja) 1985-08-31
NL7803540A (nl) 1978-10-06
AR222149A1 (es) 1981-04-30
PL205745A1 (pl) 1979-05-07
FR2395264A1 (fr) 1979-01-19
BE865642A (fr) 1978-10-03
PL112249B1 (en) 1980-10-31
DE2814168C2 (es) 1989-02-16

Similar Documents

Publication Publication Date Title
KR920005113B1 (ko) 정신병치료제 1-플루오로페닐부틸-4-(2-피리미디닐)피페라진 유도체의 제조방법.
CA2247772A1 (en) .alpha.-substituted phenylpropionic acid derivative and medicine containing the same
US3766180A (en) 3-heterocyclicamino-4-chloro-1,2,5-thiadiazoles
NO155805B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
EP0190015B1 (en) Novel 4h-1-benzopyran-4-ones and their sulphur containing analogs
US3974158A (en) 2-(Substituted anilino)methylmorpholines
HU190827B (en) Process for preparing 2-/4/-/4,4-dialkyl-1,2,6-piperidindion-1-yl/-butyl/-1-piperazinyl/-pyridines
US4404384A (en) O-[3-(4-Substituted-piperazin-1-yl)-2-hydroxypropyl]-hydroxylamines
CA1053230A (en) 4-arylpiperidine derivatives and processes for the production thereof
EP0549796A1 (en) Diphenylpiperazine derivative and drug for circulatory organ containing the same
CZ418597A3 (cs) 1,6-disubstituované izochromany pro léčbu bolestí hlavy při migréně
AU746721B2 (en) Chemical synthesis of morpholine derivatives
SE435507B (sv) Forfarande for framstellning av trimetoxifenoxi-propyl-piperezinderivat
JPS5949225B2 (ja) 化合物の製造方法
HU182290B (en) Process for producing phenyl-piperazine derivatives of 1,3,4-oxadiazolyl-phenols
HU220971B1 (hu) Eljárás 0-(3-amino-2-hidroxi-propil)-hidroximsav-halogenidek előállítására
Chapman et al. Synthesis of diastereomeric ketoconazole analogs
US3040031A (en) N-heterocyclic compounds
US5536836A (en) Process for the preparation of 2-(4-[4-(4-chloro-1-pyrazolyl)butyl]-1-piperazinyl)pyrimidine (Lesopitron)
US3929902A (en) 1-Phenyl-2, 3-butadien-1-ols
CA1110642A (en) Process for the preparation of o-alkylated hydroxylamines
HU189226B (en) Process for producing basic oxime-ethers
JPS6175A (ja) 神経弛緩剤、１‐フルオロフェニルブチル‐４‐（５‐ハロ‐２‐ピリミジニル）ピペラジン誘導体
EP0084292B1 (en) N,n-disubstituted alkenamides and phenylalkenamides, processes for their production and their use as pharmaceuticals
US4029786A (en) Morpholine derivatives for treating depression

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7803742-1

Effective date: 19911108

Format of ref document f/p: F